G1 Therapeutics, Inc. (GTHX): IPOs News

GTHX – Upsized its offering from 6.25mm shares to 7.0mm shares – $15 a share.

Key Facts Surrounding This News Item

  • GTHX had returned 0.00% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel therapeutics for the treatment of cancer in the United States. The company was founded in 2008 and is based in Research Triangle Park, North Carolina. View our full GTHX ticker page with ratings, news, and more.

Try StockNews.com Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

GTHX at a Glance

GTHX Current POWR Rating™
Overall POWR Rating™
GTHX Current Price $49.98 2.33%
More GTHX Ratings, Data, and News

GTHX Price Reaction

The day of this event (May. 16, 2017)
GTHX Closing Price0.00 N/A%
GTHX Volume0
N/A% from avg
Leading up to this event
GTHX 1-mo returnN/A%

GTHX Price Chart

More G1 Therapeutics, Inc. (GTHX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GTHX News
Page generated in 1.5073 seconds.